779 related articles for article (PubMed ID: 15215253)
1. Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors.
DiPerna G; Stack J; Bowie AG; Boyd A; Kotwal G; Zhang Z; Arvikar S; Latz E; Fitzgerald KA; Marshall WL
J Biol Chem; 2004 Aug; 279(35):36570-8. PubMed ID: 15215253
[TBL] [Abstract][Full Text] [Related]
2. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.
Sato S; Sugiyama M; Yamamoto M; Watanabe Y; Kawai T; Takeda K; Akira S
J Immunol; 2003 Oct; 171(8):4304-10. PubMed ID: 14530355
[TBL] [Abstract][Full Text] [Related]
3. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
[TBL] [Abstract][Full Text] [Related]
4. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.
Dobrovolskaia MA; Medvedev AE; Thomas KE; Cuesta N; Toshchakov V; Ren T; Cody MJ; Michalek SM; Rice NR; Vogel SN
J Immunol; 2003 Jan; 170(1):508-19. PubMed ID: 12496438
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
Jiang Z; Mak TW; Sen G; Li X
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.
Pomerantz JL; Baltimore D
EMBO J; 1999 Dec; 18(23):6694-704. PubMed ID: 10581243
[TBL] [Abstract][Full Text] [Related]
7. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.
Fitzgerald KA; McWhirter SM; Faia KL; Rowe DC; Latz E; Golenbock DT; Coyle AJ; Liao SM; Maniatis T
Nat Immunol; 2003 May; 4(5):491-6. PubMed ID: 12692549
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways.
Han KJ; Su X; Xu LG; Bin LH; Zhang J; Shu HB
J Biol Chem; 2004 Apr; 279(15):15652-61. PubMed ID: 14739303
[TBL] [Abstract][Full Text] [Related]
9. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling.
Bowie A; Kiss-Toth E; Symons JA; Smith GL; Dower SK; O'Neill LA
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10162-7. PubMed ID: 10920188
[TBL] [Abstract][Full Text] [Related]
10. Protein Kinase-Mediated Decision Between the Life and Death.
Engin A
Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
[TBL] [Abstract][Full Text] [Related]
12. TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways.
Li L; Bin LH; Li F; Liu Y; Chen D; Zhai Z; Shu HB
J Cell Sci; 2005 Feb; 118(Pt 3):555-63. PubMed ID: 15657077
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7.
Unterholzner L; Sumner RP; Baran M; Ren H; Mansur DS; Bourke NM; Randow F; Smith GL; Bowie AG
PLoS Pathog; 2011 Sep; 7(9):e1002247. PubMed ID: 21931555
[TBL] [Abstract][Full Text] [Related]
14. Ras participates in CpG oligodeoxynucleotide signaling through association with toll-like receptor 9 and promotion of interleukin-1 receptor-associated kinase/tumor necrosis factor receptor-associated factor 6 complex formation in macrophages.
Xu H; An H; Yu Y; Zhang M; Qi R; Cao X
J Biol Chem; 2003 Sep; 278(38):36334-40. PubMed ID: 12867418
[TBL] [Abstract][Full Text] [Related]
15. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense.
Harte MT; Haga IR; Maloney G; Gray P; Reading PC; Bartlett NW; Smith GL; Bowie A; O'Neill LA
J Exp Med; 2003 Feb; 197(3):343-51. PubMed ID: 12566418
[TBL] [Abstract][Full Text] [Related]
16. Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation.
Sasai M; Oshiumi H; Matsumoto M; Inoue N; Fujita F; Nakanishi M; Seya T
J Immunol; 2005 Jan; 174(1):27-30. PubMed ID: 15611223
[TBL] [Abstract][Full Text] [Related]
17. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells.
Shuto T; Xu H; Wang B; Han J; Kai H; Gu XX; Murphy TF; Lim DJ; Li JD
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8774-9. PubMed ID: 11438700
[TBL] [Abstract][Full Text] [Related]
18. Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1.
Abe T; Barber GN
J Virol; 2014 May; 88(10):5328-41. PubMed ID: 24600004
[TBL] [Abstract][Full Text] [Related]
19. Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function.
Chang SJ; Hsiao JC; Sonnberg S; Chiang CT; Yang MH; Tzou DL; Mercer AA; Chang W
J Virol; 2009 May; 83(9):4140-52. PubMed ID: 19211746
[TBL] [Abstract][Full Text] [Related]
20. Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells.
Li X; Tupper JC; Bannerman DD; Winn RK; Rhodes CJ; Harlan JM
Infect Immun; 2003 Aug; 71(8):4414-20. PubMed ID: 12874320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
